Letter to the editor
- PMID: 38622658
- PMCID: PMC11020466
- DOI: 10.1186/s13049-024-01199-w
Letter to the editor
Comment on
- doi: 10.1186/s13049-024-01188-z
References
-
- CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713–23. 10.1016/S0140-6736(19)32233-0 - DOI - PMC - PubMed
-
- Lawati KA, Sharif S, Maqbali SA, Rimawi HA, Petrosoniak A, Belley-Cote EP, et al. Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials. Intensive Care Med. 2021;47(1):14–27. 10.1007/s00134-020-06279-w - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources